Stock Events

Stock Events

Gelstat 

$0.000300
6
+$0.00+20% Friday 18:46

Statistics

Day High
0.0003
Day Low
0.0003
52W High
0.0005
52W Low
0.0002
Volume
3,449
Avg. Volume
1,013,643
Mkt Cap
1.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0
-0
-0
0
Expected EPS
N/A
Actual EPS
-0.0004

Financials

-106.57%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
700,000Revenue
-746,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GSAC. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.38B
Pfizer is a global pharmaceutical company that competes with Gelstat in the development and marketing of medications for various health conditions, including those Gelstat targets.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson operates in the pharmaceutical sector, directly competing with Gelstat in areas such as pain management and healthcare solutions.
Novartis
NVS
Mkt Cap292.07B
Novartis is a multinational pharmaceutical company that offers a wide range of healthcare products, competing with Gelstat in the pharmaceutical and healthcare market.
GSK
GSK
Mkt Cap106.31B
GlaxoSmithKline is a healthcare company that produces pharmaceuticals and vaccines, competing with Gelstat in the development of treatments for various conditions.
Merck
MRK
Mkt Cap294.03B
Merck & Co., Inc. is a global healthcare company that competes with Gelstat in the pharmaceutical industry, particularly in the areas of drug development and sales.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie is a biopharmaceutical company that competes with Gelstat in the research, development, and marketing of pharmaceutical products.
AMGEN
AMGN
Mkt Cap191.7B
Amgen is a biotechnology company that competes with Gelstat in the development of innovative therapies and pharmaceutical products.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Gelstat in the discovery, development, and delivery of medicines.
Lilly(Eli) &
LLY
Mkt Cap1.01T
Eli Lilly and Company is a global pharmaceutical company that competes with Gelstat in developing and marketing medications for various health conditions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.32B
Teva Pharmaceutical Industries is a global pharmaceutical company that competes with Gelstat in generic and specialty medicines, covering a broad range of therapeutic areas.

About

GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.
Show more...
CEO
Mr. Javier G. Acosta
Employees
2
Country
United States
ISIN
US3685331056

Listings

OTC Link
US
GSAC

0 Comments

Share your thoughts

FAQ

What is Gelstat stock price today?▼
The current price of GSAC is $0.00 USD — it has increased by +20% in the past 24 hours. Watch Gelstat stock price performance more closely on the chart.
What is Gelstat stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Gelstat stocks are traded under the ticker GSAC.
What is Gelstat market cap?▼
Today Gelstat has the market capitalization of 1.12M
What were Gelstat earnings last quarter?▼
GSAC earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Gelstat revenue for the last year?▼
Gelstat revenue for the last year amounts to 700,000 USD.
What is Gelstat net income for the last year?▼
GSAC net income for the last year is -746,000 USD.
How many employees does Gelstat have?▼
As of June 15, 2026, the company has 2 employees.
In which sector is Gelstat located?▼
Gelstat operates in the Health & Wellness sector.
When did Gelstat complete a stock split?▼
The last stock split for Gelstat was on October 21, 2003 with a ratio of 2:1.
Where is Gelstat headquartered?▼
Gelstat is headquartered in Palm City, United States.